Steven Burnette
About Steven Burnette
Steven Burnette serves as the Southeast Region Business Director at Amylyx Pharmaceuticals and has extensive experience in the biotechnology industry, having held various roles at notable companies such as Alexion Pharmaceuticals and Amgen.
Current Role at Amylyx Pharmaceuticals
Steven Burnette has been serving as the Southeast Region Business Director at Amylyx Pharmaceuticals since 2021. In this role, he is responsible for overseeing business operations and strategic initiatives within the southeastern United States. His position involves collaboration with various stakeholders to enhance the company's market presence and drive growth in the region.
Previous Experience at Alexion Pharmaceuticals
Steven Burnette held multiple positions at Alexion Pharmaceuticals, Inc. from 2011 to 2020. He began as a Regional Account Manager in the Mid-Atlantic region and later transitioned to the Southeast region. From 2015 to 2017, he served as Regional Account Manager for the Southeast, followed by a role as Regional Sales Director for Metabolics from 2017 to 2020. Additionally, he worked as Associate Director of Global Training & Development from 2012 to 2015, contributing to the company's training strategies.
Experience at Amgen
Steven Burnette worked at Amgen from 2000 to 2011, where he held various roles including Executive Biopharmaceutical Representative for Nephrology and PSR/Tampa Oncology District Trainer. His experience in these positions involved direct engagement with healthcare professionals and management of hospital systems in the Tampa/St. Petersburg, Florida area.
Educational Background
Steven Burnette studied at the University of South Florida, where he earned a Bachelor of Science degree in Marketing. His education focused on business management, marketing, and related support services, providing him with a solid foundation for his career in the biotechnology industry.
Expertise and Skills
Steven Burnette possesses expertise in utilizing Microsoft Excel for business operations and strategic planning. He has a strong background in public speaking, which enhances his leadership and marketing capabilities. His extensive experience in the biotechnology sector has equipped him with a robust understanding of industry dynamics and operational strategies.